Puma Biotechnology Cash Flow Statement 2009-2025 | PBYI

Net Income/Loss

$30.278

$21.591

$0.002

$-29.126

$-59.995

$-75.595

$-113.575

$-291.955

$-276.011

$-239.284

Total Depreciation And Amortization - Cash Flow

$11.524

$11.519

$9.84

$11.305

$10.033

$8.077

$7.384

$2.811

$1.149

$0.776

Other Non-Cash Items

$0.651

$11.753

$18.827

$39.78

$37.575

$66.611

$87.228

$108.735

$120.629

$95.113

Total Non-Cash Items

$12.175

$23.272

$28.667

$51.085

$47.608

$74.688

$94.612

$111.546

$121.778

$95.889

Change In Accounts Receivable

$16.345

$-8.368

$-7.824

$-5.983

$2.353

$-8.123

$-11.103

$-9.67

Change In Inventories

$-1.644

$-2.554

$2.583

$-3.655

$-0.284

$-0.545

$-0.596

$-2.029

Change In Accounts Payable

$-1.38

$0.449

$-4.734

$-0.902

$-7.107

$-1.526

$-7.008

$7.657

$2.231

$2.806

Change In Assets/Liabilities

$-1.033

$0.202

$-1.456

$4.022

$-1.053

$10.878

$-2.218

$-1.241

$7.525

$0.926

Total Change In Assets/Liabilities

$-3.535

$-17.854

$-44.496

$-1.309

$13.16

$23.283

$-5.142

$7.939

$12.543

$-11.073

Cash Flow From Operating Activities

$38.918

$27.009

$-15.827

$20.65

$0.773

$22.376

$-24.105

$-172.47

$-141.69

$-154.468

Net Change In Property, Plant, And Equipment

$-0.056

$-0.14

$-0.046

$-0.306

$-0.609

$-0.431

$-7.284

$-1.181

Net Change In Intangible Assets

$-12.5

$-7

$-10

$-50

Net Acquisitions/Divestitures

Net Change In Short-term Investments

Net Change In Long-Term Investments

$-20.382

$-6.485

$14.104

$-10.881

$43.449

$5.469

$-57.014

$34.995

$149.473

$-81.584

Net Change In Investments - Total

$-20.382

$-6.485

$14.104

$-10.881

$43.449

$5.469

$-57.014

$34.995

$149.473

$-81.584

Investing Activities - Other

$-3.098

Cash Flow From Investing Activities

$-20.438

$-19.125

$7.104

$-10.881

$33.403

$5.163

$-57.623

$-15.436

$142.189

$-85.863

Net Long-Term Debt

$-33.33

$-1.5

$-55

$105

$50

Net Current Debt

Debt Issuance/Retirement Net - Total

$-33.33

$-1.5

$-55

$105

$50

Net Common Equity Issued/Repurchased

$0.15

$12.5

$0.068

$1.351

$7.652

$26.685

$162.43

$233.361

Net Total Equity Issued/Repurchased

$0.15

$12.5

$0.068

$1.351

$7.652

$26.685

$162.43

$233.361

Total Common And Preferred Stock Dividends Paid

Financial Activities - Other

$-0.666

$-0.277

$-30.431

$-10

$-13.418

$-4.201

$-1.575

Cash Flow From Financial Activities

$-33.846

$12.223

$-31.931

$-9.932

$-67.067

$108.451

$75.11

$162.43

$233.361

Net Cash Flow

$-15.366

$7.884

$3.5

$-22.162

$24.244

$-39.528

$26.723

$-112.796

$162.929

$-6.97

Stock-Based Compensation

$8.245

$10.247

$11.826

$32.633

$36.575

$57.327

$86.939

$108.735

$117.264

$94.934

Common Stock Dividends Paid